Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 489
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 281
CD39/CD73/A2AR pathway and cancer immunotherapy
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 154
Catch me if you can: how AML and its niche escape immunotherapy
Sarah Tettamanti, Alice Pievani, Andrea Biondi, et al.
Leukemia (2021) Vol. 36, Iss. 1, pp. 13-22
Open Access | Times Cited: 132
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 111
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 93
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu, Meixin Shi, Yuqing Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 87
Microenvironmental influences on T cell immunity in cancer and inflammation
Darren R. Heintzman, Emilie L. Fisher, Jeffrey C. Rathmell
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 316-326
Open Access | Times Cited: 76
Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 66
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D. Klysz, Carley Fowler, Meena Malipatlolla, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 266-282.e8
Open Access | Times Cited: 54
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
Alex G. Hamilton, Kelsey L. Swingle, Ryann A. Joseph, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Open Access | Times Cited: 48
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 43
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Yan-Ruide Li, Tyler Halladay, Lili Yang
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 26
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 19
Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy
Tao Lei, Yazhuo Wang, Yuchen Zhang, et al.
Leukemia (2024)
Open Access | Times Cited: 18
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
Yan-Ruide Li, Kuangyi Zhou, Derek Lee, et al.
Nature Protocols (2025)
Closed Access | Times Cited: 2
Unlocking the potential of engineered immune cell therapy for solid tumors
Víctor Albarrán, Laura Angelats, Julio Delgado, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies
Zhengzheng Zhang, Tian Wang, Xiaofeng Wang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106036-106036
Open Access | Times Cited: 73
Intraparticle Double‐Scattering‐Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR‐T Therapy
Duo Wang, Mengqi Zhang, Yan Zhang, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 55
CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
Wei Wei, Zhi‐Nan Chen, Ke Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12317-12317
Open Access | Times Cited: 41
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Yalan Zhang, Weilin Zhou, Jianping Yang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Bright future or blind alley? CAR-T cell therapy for solid tumors
Kai Zhang, Hong Chen, Fuqiang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
Yufeng Wang, David L. Drum, Ruochuan Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy
John Stagg, Encouse B. Golden, Erik Wennerberg, et al.
Science Immunology (2023) Vol. 8, Iss. 85
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top